Ptc Therapeutics (PTCT) Asset Utilization Ratio (2016 - 2025)
Historic Asset Utilization Ratio for Ptc Therapeutics (PTCT) over the last 13 years, with Q3 2025 value amounting to 0.67.
- Ptc Therapeutics' Asset Utilization Ratio rose 7746.24% to 0.67 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.67, marking a year-over-year increase of 7746.24%. This contributed to the annual value of 0.45 for FY2024, which is 1395.88% down from last year.
- As of Q3 2025, Ptc Therapeutics' Asset Utilization Ratio stood at 0.67, which was up 7746.24% from 0.67 recorded in Q2 2025.
- Ptc Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.73 during Q1 2025, with a 5-year trough of 0.2 in Q1 2021.
- Over the past 5 years, Ptc Therapeutics' median Asset Utilization Ratio value was 0.41 (recorded in 2022), while the average stood at 0.44.
- As far as peak fluctuations go, Ptc Therapeutics' Asset Utilization Ratio tumbled by 4118.19% in 2024, and later soared by 7746.24% in 2025.
- Ptc Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.27 in 2021, then skyrocketed by 55.97% to 0.43 in 2022, then surged by 39.58% to 0.59 in 2023, then tumbled by 41.18% to 0.35 in 2024, then skyrocketed by 92.84% to 0.67 in 2025.
- Its last three reported values are 0.67 in Q3 2025, 0.67 for Q2 2025, and 0.73 during Q1 2025.